Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

ANALGESIC GEL, TOPICAL

Active
SPE2DP-26-T-4115Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract specifies the procurement of an analgesic gel for topical use containing 5% menthol USP, supplied in 4 oz tubes with 144 tubes per case, classified as a flammable hazardous material requiring storage at 20–25°C (68–77°F) and protection from excessive heat or open flame. The item is identified by NSN 6505-01-658-7643 with a non-extendable shelf life of 24 months and must be packaged in commercial-grade containers that ensure protection from damage during transport, conforming to Medical Marking Standard No. 1 instead of MIL-STD-129. Shipment of the product must adhere to applicable hazard communication regulations, including the submission of Safety Data Sheets compliant with 29 C.F.R. 1910.1200 prior to award, and each shipment must include an accompanying SDS. Labels must meet OSHA’s revised Hazard Communication Standard aligned with the Globally Harmonized System, and supplier employees must be trained on these requirements. Packaging and transportation must comply with 49 CFR and ICAO regulations due to the flammable nature of the product, and all materials must be marked and documented in accordance with DLA’s hazardous material protocols, including electronic submission of SDS to DLA.MSDS@DLA.MIL. The contract is issued under solicitation SPE2DP-26-T-4115, requiring delivery within 20 days to Waterveciet, NY, and is managed by the Department of Defense’s Medical Supply Chain.

General Info

5% menthol analgesic gel in 4 oz tubes, flammable, 24-month shelf life, SDS required, DLA hazardous shipping rules.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

1 BUFFINGTON STREET BLDG 145, WATERVLIET, NY, 12189-0000, US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4115 Medical Supply Chain

PDF•rfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
Lawrence Garnett
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
ANALGESIC GEL,TOPICAL
ANALGESIC GEL,TOPIC Menthol USP 5%, topical, analgesic gel; 4 oz (118 ml) tubes, 144 per case; flammable; keep away from excessive heat or open flame. UNIT OF ISSUE "CASE" Store at 20-25°C (68-77°F)
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
Hazard Communication Standard Notice:
Effective June 1, 2015, Federal Standard No. 313-E, Material Safety Data, Transportation Data and Disposal Data for Hazardous Materials Furnished to Government Activities, establishes the requirement for preparation and submission of Safety Data Sheets (SDS) in lieu of Material Safety Data Sheets (MSDS) by suppliers who provide hazardous materials to government activities.
The Occupational Safety and Health Administration (OSHA) has modified its Hazard Communication Standard (HCS) to conform to the United Nations Globally Harmonized System of Classification and Labeling of Chemicals. As a result of this change, GSA revised Federal Standard No. 313-E requiring Safety Data Sheets for classifying chemicals and communicating the applicable information on labels.
In accordance with the revised standard after June 1, 2015:
1. Suppliers will be required to submit, to the contracting officer for review and approval prior to award, safety data sheets consistent with the requirements found at 29 C.F.R. 1910.1200 for hazardous materials delivered to the Government.
2. Suppliers will also be required to submit, to the contracting officer for review and approval prior to award, Hazardous Communication Standard (HCS) labels in accordance with 29 C.F.R. 1910.1200 requirements or current Consumer Product Safety Act (CPSA), Federal Hazardous Substance Act (FHSA) labels when subject to labeling requirements under those statutes. This product labeling is required for hazardous materials delivered to the Government.
3. Finally, suppliers must train their employees on the new safety data sheets, hazardous communication labels, and requirements of 29 C.F.R. 1910.1200.
For more information on SDS, refer to OSHAs website, available at:
https://www.osha.gov/law-regs.html
SPE2DP-26-T-4115
SECTION B
For information on 29 C.F.R. 1910.1200, refer to the below link:
https://www.osha.gov/dsg/hazcom/index.html RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RQ034: HAZARDOUS COMMUNICATION STANDARD NOTICE
.
HAZARDOUS MATERIALS REQUIREMENTS.
.
MATERIAL SAFETY DATA SHEET (MSDS).
.
. A CURRENT MSDS SHALL BE PROVIDED FOR THIS
ITEM. DLA'S DOD HMIRS FOCAL POINT (VBA) HAS
ESTABLISHED AN ELECTRONIC MAILBOX TO WHICH
ONE CAN TRANSMIT THE MSDS, TOGETHER WITH THE
COVER SHEET (P-75) WHOSE CONTENTS ARE TO
REFLECT LOGISTICS INFORMATION PROPER TO THE
MSDS ASSOCIATED WITH THE AWARDED CONTRACT AND
NSN. THE ELECTRONIC MAILBOX ADDRESS IS
DLA.MSDS@DLA.MIL.
.
. IN ADDITION, A COPY OF THE MSDS SHALL
ACCOMPANY EACH SHIPMENT OF THIS ITEM.
.
PACKAGING.
.
. PACKAGING FOR HAZARDOUS MATERIALS SHALL
COMPLY WITH APPLICABLE REGULATIONS, I.E.<(>,<)>
49 CFR, INTERNATIONAL CIVIL AVIATION
ORGANIZATION (ICAO) TECHNICAL NSN/Part Number: 6505-01-658-7643 Quantity: 1 CS Purchase Request: 7017471614QTY: 1 Delivery: 20 days ADO

Similar Contracts

NAICS: 325411
New
DIBBS
KETOROLAC TROMETHAMINEKetorolac Tromethamine Injection, USP 15 mg per mL in prefilled syringes, 24’s per unit, is being procured under contract SPE2DP-26-T-4143 for delivery to Fort Bragg, North Carolina, with a required delivery date of July 13, 2026, and a five-day delivery window. The item is identified by NSN 6505-01-666-2156 and NDC 76045-0107-10, manufactured by FRESENIUS KABI, LLC, and must comply with DLA’s Master List of Technical and Quality Requirements, including Packaging Requirement RP001 and Shelf-life requirement RS016, which mandates a non-extendable 24-month shelf life. All packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and units must be sealed in commercial containers that ensure protection from damage during transit. The product must be shipped by the fastest traceable means, excluding parcel post, and labeled according to current Hazard Communication Standards (29 C.F.R. 1910.1200), including OSHA-compliant Safety Data Sheets and labels, as mandated post-June 2015. The quantity is one unit of issue (PG), with zero variance permitted, and inspection and acceptance occur at the destination. Packaging and palletization must follow DLA specifications, and government identification must not appear on non-accepted supplies. The contract requires full compliance with all applicable DLA technical and quality requirements, which take precedence over ASTM D3951 or other general commercial standards.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 6 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
REHYDRATION SALTS FThe contract is for Rehydration Salts F, a regulated medical product under FDA oversight, requiring confirmation of compliance with marketing requirements including registration, labeling, and Good Manufacturing Practices, though a 510(k) may not be required. The item has a non-extendable 24-month shelf life and must be marked in accordance with the latest edition of Medical Marking Standard No. 1 and MIL-STD-129, with packaging conforming to MIL-STD-2073-1E and DLA packaging requirements. The product is identified by NSN 6505-01-731-1574 and supplier part number 61436, provided by DRIP DROP HYDRATION INC. A total of two cases are to be delivered FOB destination within five days of contract award, with no variance allowed in quantity. Delivery is to Fort Stewart, Georgia, and shipping must occur via the fastest traceable means, excluding parcel post. The required delivery date is July 16, 2026, and the solicitation closes on July 21, 2026. The contract uses the DoD unit of issue and includes specific markings, packaging codes, and government-only identifiers. The contracting officer must submit an EBS referral for FDA product confirmation, including manufacturer and bidder details.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 6 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
BENZOCAINE AND MENTHOLBenzocaine and Menthol Lozenge, manufactured by RB Health US LLC and Reckitt Benckiser LLC, is a 15 mg benzocaine and 2.6 mg menthol oral pain reliever in honey lemon flavor, packaged in units of 16 lozenges, with a shelf life of 36 months that is non-extendable. The product must be stored at 20-25°C (68-77°F) and protected from humidity. All medical acquisitions require commercial packaging that ensures protection from damage or breakage, with each unit sealed in an appropriate container and shipped in exterior containers that guarantee safe, low-cost delivery to the destination. Material must be marked in accordance with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and packaging must comply with DLA’s packaging requirements and palletization standards. The item is identified by NSN 6505017081449 and NDC 63824-0732-16, and is procured across five contract line items totaling 58 package units, each priced at $1.00 per unit, for total contract value of $58.00. Delivery is required within 20 days, FOB destination, with zero variance allowed in quantity, inspection and acceptance occurring at the delivery point. Shipments must be traceable, excluding parcel post, and sent to designated military logistics addresses at Fort Bragg, North Carolina, and Fort Stewart, Georgia. The solicitation, issued by the Department of Defense under contract SPE2DP-26-T-4113, has a response deadline of July 20, 2026, and requires compliance with all technical and quality requirements listed in the DLA Master List.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 325411
New
DIBBS
Manufacturing of Chlorine Test Strips (INSTA-TEST STRIPS Model 600S)
MEDICAL SUPPLY CHAIIN FSH

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
SUMATRIPTAN SUCCINATESumatriptan Succinate Tablets, 100 mg in bottles of 9 tablets, are procured under solicitation SPE2DP-26-T-4106 for acute treatment of migraines with or without aura in adults. The product must comply with strict storage requirements of 20 to 25°C (68 to 77°F), protected from light, and carries a non-extendable 24-month shelf life as a Type I (Code M) item. All packaging and marking must adhere to MIL-STD-2073-1E and MIL-STD-129, with palletization following DLA’s RP001 packaging standards and medical marking in alignment with Medical Marking Standard No. 1. The item is regulated by the FDA, requiring buyer referrals for confirmation before award. Three line items total 11 bottles, with delivery dates set for July 15–16, 2026, and a 20-day delivery window. Shipments are to be sent via traceable freight to designated military addresses in APO AE and Hampton, VA, with no parcel post permitted. The contract specifies zero variance in quantity, with inspection and acceptance occurring at destination. The manufacturer is Mylan Pharmaceuticals Inc. under NDC 00378-5632-59 and Golden State Medical Supply, Inc. under NDC 51407-0013-09, with packaging and labeling meeting all defense logistics agency technical and quality requirements referenced in the DLA Master List.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details